<span id="ldtbo"></span>

<track id="ldtbo"><div id="ldtbo"></div></track>
    <tbody id="ldtbo"></tbody>

      1. <tbody id="ldtbo"><nobr id="ldtbo"><address id="ldtbo"></address></nobr></tbody>
      2. <option id="ldtbo"><div id="ldtbo"></div></option>
      3. <track id="ldtbo"></track>

          <menuitem id="ldtbo"></menuitem><bdo id="ldtbo"></bdo>
        1. <tbody id="ldtbo"><div id="ldtbo"><td id="ldtbo"></td></div></tbody>

            <track id="ldtbo"></track>

            Welcome to the
            neighborhood of better.
            Welcome to Solera.

            We’re committed to providing a better Specialty Pharmacy experience with better access to medication, better education, and better support. Not because it’s our business, but because it’s our community.

            Solera is a Specialty Pharmacy with a smaller focus and a much larger impact. With a proven track record and the latest accreditations, we provide the support and treatment patients need with a personalized approach. Our highly communicative and professional nature has earned us the trust of payors, providers and prescribers everywhere. Solera is everything you expect out of a Specialty Pharmacy—simply better.

            Learn More


            • URAC Accredited

            • ACHC Accredited

            • Verified Internet Pharmacy Practice Sites? (VIPPS?)

            Start your enrollment with us today! It’s simple with our easy to download and fillout forms.

            See All

            News & Events See All

            • News

              March 22, 2018

              Cimzia Label Update Provides New Information For Women Of Childbearing Age

              Read Article
            • News

              March 5, 2018

              Review Finds Switching From Reference Product To Biosimilar ‘Not Inherently Dangerous’

              Read Article
            • News

              January 30, 2018

              SVR For HCV With No Advanced Liver Disease Greatly Reduces Mortality Risk

              Read Article
            • News

              February 13, 2018

              Novartis Gains U.S. Approval For Glatopa For Multiple Sclerosis

              Read Article

            Need help getting started? Get in touch with us! We are always here to help you.

            Get in Touch

            Contact Us